Creative Biolabs-Lipid Based Drug Delivery

Ultrasomes

Besides the expertise in delivery system design and engineering, Creative Biolabs is also dedicated to the areas of LDD formulation for drug packaging and disease treatment by developing customized drug delivery systems with various advanced technology methods. With more than 10 years of experience in bio-conjugation chemistry, the science team at Creative Biolabs can provide customers all over the world with comprehensive services from design to the production.

Introduction

Ultrasomes are one of the vesicular systems in which UV-endonuclease enzymes encapsulated in multilamellar liposomes. The endonuclease is from Micrococcus luteus. Endonucleases are a kind of enzymes that cleave the phosphodiester bond within a polynucleotide chain, such as deoxyribonuclease I, cut DNA relatively nonspecifically, while some restriction endonucleases or restriction enzymes, cleave only at very specific nucleotide sequences. However, UV damage endonuclease (UVDE) is a distinct DNA-repair enzyme that can recognize and incise different types of damaged DNA, it is a DNA endonuclease that not only recognizes and incises DNA 5’ to cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs), but also non-UV-induced DNA damage such as abasic sites, nicks and gaps. Thus, the natural DNA repair activity for humans is facilitated by of the UV-endonuclease enzymes in ultrasomes.

Fig.1 Liposomes. (By SuperManu - Own work, CC BY-SA 3.0, https://en.wikipedia.org/wiki/File:Liposome_scheme-en.svg) Fig.1 Liposomes.

Ultrasomes-based Drug Delivery

Ultrasomes are specialized liposomes encapsulating a UV-endonuclease enzyme. Endonuclease recognizes ultra violet (UV) damage and is reported to increase the speed of repair by up to 4 times. Ultrasomes also involved in protecting the immune system by repairing UV-DNA damage and decreasing the expression of tumor necrosis factor (TNF-α), interleukins (IL-1, IL-6 and IL-8). Ultrasomes also can induce the production of melanin by melanocytes in the tanning response following UV exposure and are used in cosmeceuticals and anti-aging formulations. It has been shown a dose-dependent response in vitro detection. Currently, the liposomes (200 nanometers) are formed from pure and 100% natural egg phospholipids.

Ultrasomes is a translucent suspension with a pH of 7.0 - 8.0. Since light activation is not required, Ultrasomes can be used in nighttime skin care products. They are compatible with hydrogels, carbomers, emulsifiers, triethanolamine, dimethicone, sunscreens & sun blocks and phenoxyethanol; incompatible with anionic or ionic detergents and surfactants, 5% ethylene glycol, glycerin or alcohol. The preservative is 1% phenoxyethanol.

Features of Our Ultrasomes-based Drug Delivery

  • Advanced platform
  • Experienced scientist
  • Timely and efficient
  • Cost-effective

Creative Biolabs is one of the forward-looking antibody research institution and provider who leads the development of the era while offering the best service to the customers around the world. Creative Biolabs is pleased to provide high-quality ultrasomes-based drug delivery services to contribute to your project. Our drug delivery systems may help the administration of all kinds of drugs for our worldwide customers. If you are interested in our services, please feel free to contact us for more details and information.

For Research Use Only. Not For Clinical Use

Supports

Formulation Science Background of Liposome Research Highlights
Resources Technical Supports Featured Services Knowledge Center
Optimizing LNP Molar Ratios for Transfection Efficiency
Scalability Challenges in mRNA-LNP Manufacturing
Beyond mRNA: LNP Delivery for CRISPR/Cas9
Cationic Lipids Evolution: DOTAP to Ionizable Lipids
LNP Storage Stability: Lyophilization vs. Liquid
Modulating LNP Biodistribution: Overcoming Liver Accumulation
Active vs. Passive Targeting (EPR): A Guide to Tumor Drug Delivery
Immunoliposomes: Comparing Pre-insertion vs. Post-insertion Techniques
Crossing the BBB: Advances in Transferrin and Peptide-Modified Liposomes
pH-Responsive Liposomes for Tumor Microenvironment
Thermosensitive Liposomes combined with HIFU
Aptamer-Modified Liposomes: A Cost-Effective Antibody Alternative
Ethosomes vs Transfersomes for Dermal Delivery
Strategies for Encapsulating Poorly Water-Soluble Small Molecules in Liposomes
Multivesicular Liposomes: The Architecture of Sustained Release
Mechanisms of Liposomal Adjuvants in Enhancing Vaccine Immune Response
Protecting Enzymatic Activity: Liposomal Encapsulation Strategies for Enzymes
Cryo-TEM vs. DLS: Interpreting Discrepancies in Liposome Particle Size Data
Validating In Vitro Release Methods: Dialysis vs. Sample Separation Techniques
Predicting Long-Term Stability of Liposomal Suspensions using Zeta Potential
Troubleshooting Low Liposome Encapsulation Efficiency
Application of Multi-omics Analysis in Liposome Toxicology Assessment
The Ultimate Guide to Liposome Preparation
Fluorescent Liposomes for Cellular Uptake: Labeling, Controls, and Troubleshooting
How to Design Stealth Liposomes for Long Circulation
Homemade vs. Commercial Kits: Why Standardization Matters in Liposome Research

Online Inquiry